Methods
reticular abnormality, fibrosing ILD, pulmonary fibrosis
PULMONARY FIBROSIS, TRACTION BRONCHIECTASIS
The INBUILD trial enrolled patients with fibrosing ILD (reticular abnormality with traction bronchiectasis, with or without honeycombing) on high-resolution computed tomography of >10% extent. Patients had shown progression of pulmonary fibrosis within the prior 24 months, despite management in clinical practice. Subjects were randomised to receive nintedanib or placebo.